MEDPACE HOLDINGS INC (MEDP)

US58506Q1094 - Common Stock

346.29  +4.47 (+1.31%)

Buy % Consensus

75

ChartMill assigns a Buy % Consensus number of 75% to MEDP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 389.67. This target is 12.53% above the current price.
MEDP was analyzed by 16 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about MEDP.
In the previous month the buy percentage consensus was at a similar level.
MEDP was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 346.29339.36404.94389.67456.75 - -2.00% 16.94% 12.53% 31.90%
Up and Down Grades
Date Firm Action Rating
2024-10-23 TD Cowen Maintains Buy -> Buy
2024-10-23 Baird Downgrade Outperform -> Neutral
2024-10-22 William Blair Reiterate Outperform
2024-10-14 Redburn Atlantic Initiate Buy
2024-10-14 Truist Securities Maintains Hold -> Hold
2024-09-27 UBS Downgrade Buy -> Neutral
2024-09-25 Jefferies Downgrade Buy -> Hold
2024-09-20 Baird Maintains Outperform -> Outperform
2024-09-11 William Blair Reiterate Outperform
2024-08-01 Truist Securities Initiate Hold
2024-07-24 TD Cowen Maintains Buy -> Buy
2024-07-24 Guggenheim Maintains Buy -> Buy
2024-07-24 Deutsche Bank Maintains Hold -> Hold
2024-07-24 Baird Maintains Outperform -> Outperform
2024-07-23 William Blair Reiterate Outperform
2024-07-08 Baird Maintains Outperform -> Outperform
2024-05-29 TD Cowen Initiate Buy
2024-05-28 Mizuho Initiate Buy
2024-04-24 Guggenheim Maintains Buy -> Buy
2024-04-24 Baird Maintains Outperform -> Outperform
2024-04-23 Jefferies Upgrade Hold -> Buy
2024-03-18 Deutsche Bank Initiate Hold
2024-03-08 UBS Maintains Buy -> Buy
2024-02-15 UBS Upgrade Neutral -> Buy
2024-02-14 Baird Maintains Outperform -> Outperform
2024-01-17 Baird Maintains Outperform -> Outperform
2023-10-24 Baird Upgrade Neutral -> Outperform
2023-07-25 Guggenheim Maintains Buy -> Buy
2023-05-08 Guggenheim Upgrade Neutral -> Buy
2023-02-15 Baird Maintains Neutral